A-1155463 : BH3 mimetic of BCL2L1



Protein target names: BCL2L1

Mechanism of action: BH3 mimetic

Recommended in-cell concentration:
50-500 nM
Primary References:

In Vitro Validations

Uniprot ID: Q07817
Target Class: Other
Target SubClass: Apoptosis regulator
Potency: Ki
Potency Value: <0.01 nM
Potency Assay: Time-resolved, flourecence resonance energy transfer (TR-FRET) assays
PDB ID for probe-target interaction (3D structure): 4QVX
Structure-activity relationship: Yes, see PMID: 25313317
Target aliases:
Bcl-2-like protein 1, BCLX, BCL2L, BCL2L1, B2CL1_H ...

In Cell Validations

In Vivo Data

Reagent authentication certificate: PDF image

I have extra information to add

SERP ratings and comments

SERP Ratings

In Cell Rating
In Model Organisms

(last updated: 25 Apr 2017 )

SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

This is a very promising probe.

(last updated: 19 May 2017 )

SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

This probe is a selective picomolar inhibitor of BCL-XL. I recommend to use this probe to interrogate BCL-XL target in cells. It should be used in combination with ABT-199 (a selective inhibitor of BCL-2) to decouple BCL-XL and BCL-2 pathways. One concern, however, is that the molecule binds BCL-W (Ki=19 nM), and yet it inhibits H146 cells in 10% human serum with EC50=65 nM, which is close to Ki for BCL-W. Thus, BCL-W is a potential off target. As for in vivo use, this probe may be used with caution since its tissue and organ distribution were not reported. It does affect platelet counts (dependence on BCL-XL).

(last updated: 12 Jun 2017 )